Fluocinonide
Half-Life (t½) TD: 8h
Formula C26H32F2O7
Molecular Weight 494.53 g/mol
Aliases Lidex Pharmacological Mechanism High-potency topical glucocorticoid (Class II). Used for moderate-severe inflammatory dermatoses where Class III–IV agents have failed. Skin atrophy + striae + perioral dermatitis at chronic facial use.
Half-Life & Elimination Curve (TD: 8h) 100% 50% 25% 12.5% 0% 0h 0×t½ 8h 1×t½ 16h 2×t½ 24h 3×t½ 32h 4×t½ 40h 5×t½ 0×t½ (0h): 100% remaining 1×t½ (8h): 50% remaining 2×t½ (16h): 25% remaining 3×t½ (24h): 12.5% remaining 4×t½ (32h): 6.3% remaining 5×t½ (40h): 3.1% remaining Elimination (TD)
0×t½ 0h 100% 1×t½ 8h 50% 2×t½ 16h 25% 3×t½ 24h 12.5% 4×t½ 32h 6.3% 5×t½ 40h 3.1% Dosing Guidelines Transdermal (TD): Typical 0.05 mg (Range: 0.05–0.5 mg)Target Organ Systems Musculoskeletal System Integumentary System Immune & Hematologic Chemical Structure & Identifiers InChIKey: WJOHZNCJWYWUJD-IUGZLZTKSA-NSMILES: CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)C=C[C@@]54C)F)F)O)C)OC(O2)(C)CDirectory Compounds Registry Human Biology Hub